These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18397685)

  • 21. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
    Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
    Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
    Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
    BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Level of evidence for therapeutic drug monitoring of vancomycin].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock.
    Borsuk-De Moor A; Rypulak E; Potręć B; Piwowarczyk P; Borys M; Sysiak J; Onichimowski D; Raszewski G; Czuczwar M; Wiczling P
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma kallistatin in critically ill patients with severe sepsis and septic shock.
    Lin WC; Chen CW; Chao L; Chao J; Lin YS
    PLoS One; 2017; 12(5):e0178387. PubMed ID: 28542440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock.
    Linder A; Åkesson P; Inghammar M; Treutiger CJ; Linnér A; Sundén-Cullberg J
    Crit Care; 2012 May; 16(3):R90. PubMed ID: 22613179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating erythropoietin and interleukin-6 concentrations increase in critically ill children with sepsis and septic shock.
    Krafte-Jacobs B; Bock GH
    Crit Care Med; 1996 Sep; 24(9):1455-9. PubMed ID: 8797615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical laboratory-based assay methodologies may underestimate and increase variability of vancomycin protein binding in hospitalized patients.
    Crandon JL; MacVane SH; Nicolau DP
    Pharmacotherapy; 2014 Feb; 34(2):203-9. PubMed ID: 23798336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock.
    Zelenitsky S; Rubinstein E; Ariano R; Iacovides H; Dodek P; Mirzanejad Y; Kumar A;
    Int J Antimicrob Agents; 2013 Mar; 41(3):255-60. PubMed ID: 23312606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are higher vancomycin doses needed in ventricle-external shunted patients?
    Pujal M; Soy D; Codina C; Ribas J
    Pharm World Sci; 2006 Aug; 28(4):215-21. PubMed ID: 17066239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adherence to international guidelines on early management in severe sepsis and septic shock].
    Quintero RA; Martínez CA; Gamba JD; Ortiz I; Jaimes F
    Biomedica; 2012 Sep; 32(3):449-56. PubMed ID: 23715193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
    Jochberger S; Dörler J; Luckner G; Mayr VD; Wenzel V; Ulmer H; Morgenthaler NG; Hasibeder WR; Dünser MW
    Crit Care Med; 2009 Feb; 37(2):476-82. PubMed ID: 19114902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can bioimpedance determine the volume of distribution of antibiotics in sepsis?
    Balik M; Sedivy J; Waldauf P; Kolar M; Smejkalova V; Pachl J
    Anaesth Intensive Care; 2005 Jun; 33(3):345-50. PubMed ID: 15973917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
    Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
    J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of glycopeptide antibiotics by cytokine hemoadsorption in patients with septic shock: A study of three cases.
    Dimski T; Brandenburger T; MacKenzie C; Kindgen-Milles D
    Int J Artif Organs; 2020 Dec; 43(12):753-757. PubMed ID: 32342769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit].
    Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M
    Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial dosage regimen of vancomycin for septic shock patients: a pharmacokinetic study and Monte Carlo simulation.
    Katip Bpharm W; Jaruratanasirikul S; Pattharachayakul S; Wongpoowarak W; Jitsurong A
    J Med Assoc Thai; 2014 Nov; 97(11):1209-19. PubMed ID: 25675687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
    Pea F; Porreca L; Baraldo M; Furlanut M
    J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.